MetLife Investment Management, LLC - GENERATION BIO CO ownership

GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 86 filers reported holding GENERATION BIO CO in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of GENERATION BIO CO
ValueSharesWeighting
Q3 2023$91,077
-31.1%
24,0310.0%0.00%0.0%
Q2 2023$132,171
+27.8%
24,031
-8.7%
0.00%0.0%
Q4 2022$103,426
-26.0%
26,3170.0%0.00%0.0%
Q3 2022$139,743
-19.1%
26,3170.0%0.00%0.0%
Q2 2022$172,640
+18.9%
26,317
+33.0%
0.00%0.0%
Q1 2022$145,244
+497.9%
19,788
+476.7%
0.00%
Q4 2021$24,291
-93.8%
3,431
-78.0%
0.00%
-100.0%
Q3 2021$391,242
-11.9%
15,6060.0%0.00%0.0%
Q1 2021$444,147
+179.5%
15,606
+178.4%
0.00%
+100.0%
Q4 2020$158,902
-8.3%
5,6050.0%0.00%0.0%
Q3 2020$173,2515,6050.00%
Other shareholders
GENERATION BIO CO shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Life Science Advisors, LLC 8,279,484$35,601,7814.82%
GREAT POINT PARTNERS LLC 1,022,537$4,396,9090.86%
Artal Group S.A. 2,814,191$12,1010.72%
PFM Health Sciences, LP 2,648,297$11,387,6770.50%
SVB FINANCIAL GROUP 40,401$173,7240.33%
SECTORAL ASSET MANAGEMENT INC 385,070$1,655,8010.32%
Yiheng Capital Management, L.P. 1,601,766$6,887,5940.27%
EcoR1 Capital, LLC 1,956,579$8,413,2900.27%
HARVARD MANAGEMENT CO INC 510,354$2,194,5220.23%
Bellevue Group AG 3,620,280$15,567,2040.23%
View complete list of GENERATION BIO CO shareholders